← All trials
NCT03510572
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 4, 2018
- Primary completion
- Jul 31, 2019
- Completion date
- Jul 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of UlsanLead sponsor
- University of UlsanReponsible party - principal investigator
- Korea Health Industry Development InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.